Results 11 to 20 of about 5,244 (166)

Sustained Belinostat‐Induced Metabolic Response and Tolerability in Heavily Pretreated Relapsed/Refractory Angioimmunoblastic T‐Cell Lymphoma: A Case Report

Clinical Case Reports
Angioimmunoblastic T‐cell lymphoma (AITL), a rare and aggressive subtype of peripheral T‐cell lymphoma (PTCL), often demonstrates resistance to standard therapies.
Vassiliki Labropoulou, Evgenia Verigou, Eleni P. Kourea, Maria Liga, Dimitrios Tsokanas, Krisela‐Christina Valera, Alexandros Spyridonidis   +6 more
doaj   +2 more sources

A phase I dose-escalation study of neoantigen-activated haploidentical T cell therapy for the treatment of relapsed or refractory peripheral T-cell lymphoma

Frontiers in Oncology, 2022
Peripheral T-cell lymphoma (PTCL) is a type of highly heterogeneous non-Hodgkin lymphoma with a poor prognosis and lack of effective targeted therapies. Adoptive T-cell therapy has been successfully used in the treatment of B-cell malignancies.
Yuan Chen, Hu Zhao, Jing Luo, Youping Liao, Xu Dan, Guoyu Hu, Weiyue Gu   +6 more
doaj   +1 more source

Angioimmunoblastic T-Cell Lymphoma [PDF]

Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Review on Angioimmunoblastic T-cell lymphoma, with data on clinics, and the genes involved.
Leticia Quintanilla-Martinez, German Ott
openaire   +2 more sources

Prolonged chemotherapy for angioimmunoblastic T-cell lymphoma

Клиническая онкогематология, 2014
Introduction: Current СНОР-like therapy for angioimmunoblastic T-cell lymphoma demonstrates unsatisfactory results with respect to the achievement of complete remission.
N. G. Chernova, Yu. E. Vinogradova, Yu. V. Sidorova, I. B. Kaplanskaya, E. A. Gilyazitdinova, L. G. Gorenkova, D. S. Marin, A. M. Kremenetskaya, A. I. Vorobyev, S. K. Kravchenko   +9 more
doaj   +1 more source

Chemotherapy combined with radiotherapy for successful treatment of angioimmunoblastic T-cell lymphoma: a case report

Journal of Medical Case Reports, 2020
Background The incidence of angioimmunoblastic T-cell lymphoma is rare worldwide, and it has a poor prognosis. There is no proven or standard first-line therapy that works for the majority of patients with angioimmunoblastic T-cell lymphoma because of ...
Yudi Xiong, Lei Yang, Jing Dai, Fuxiang Zhou, Yunfeng Zhou   +4 more
doaj   +1 more source

Angioimmunoblastic T-cell lymphoma presenting as giant kidneys: a case report

Journal of Medical Case Reports, 2009
Introduction Angioimmunoblastic T-cell lymphoma is a rare form of tumor of the lymph nodes or lymphoid tissue. In this report we describe an unusual presentation of angioimmunoblastic T-cell lymphoma consisting of giant kidneys with no nephrotic syndrome.
Argov Ori, Charach Gideon, Weintraub Moshe, Shtabsky Alexander   +3 more
doaj   +1 more source

Epstein–Barr virus positive diffuse large B‐cell lymphoma transformed into angioimmunoblastic T‐cell lymphoma after treatment

Clinical Case Reports, 2021
Angioimmunoblastic T‐cell lymphoma (AITL) is the subtype of mature T‐cell non‐Hodgkin lymphoma. Compared with diffuse large B‐cell lymphoma (DLBCL), AITL patients are frequently accompanied with Epstein–Barr virus (EBV) infection.
Chaoyu Wang, Yi Gong, Qingming Jiang, Xiping Liang, Rui Chen   +4 more
doaj   +1 more source

Renal infarction due to polyarteritis nodosa in a patient with angioimmunoblastic T-cell lymphoma: a case report and a brief review of the literature

Diagnostic Pathology, 2012
Angioimmunoblastic T-cell lymphoma is one of the most common subtypes of peripheral T-cell lymphoma (15-20% of all cases), accounting for approximately 1-2% of all non-Hodgkin lymphomas.
Ambrosio Maria, Rocca Bruno, Ginori Alessandro, Onorati Monica, Fabbri Alberto, Carmellini Mario, Lazzi Stefano, Tripodi Sergio   +7 more
doaj   +1 more source

The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation

Haematologica, 2010
Background T follicular helper (TFH) cells reside in the light zone of germinal centers and are considered the cell of origin of angioimmunoblastic T-cell lymphoma.
Teresa Marafioti, Jennifer C. Paterson, Erica Ballabio, Andreas Chott, Yasodha Natkunam, Manuel Rodriguez-Justo, Anne Plonquet, Socorro M. Rodriguez-Pinilla, Wolfram Klapper, Martin-L. Hansmann, Stefano A. Pileri, Peter G. Isaacson, Harald Stein, Miguel A. Piris, David Y. Mason, Philippe Gaulard   +15 more
doaj   +1 more source

Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma

Haematologica, 2016
CTLA4 and CD28 are co-regulatory receptors with opposite roles in T-cell signaling. By RNA sequencing, we identified a fusion between the two genes from partial gene duplication in a case of angioimmunoblastic T-cell lymphoma.
Hae Yong Yoo, Pora Kim, Won Seog Kim, Seung Ho Lee, Sangok Kim, So Young Kang, Hye Yoon Jang, Jong-Eun Lee, Jaesang Kim, Seok Jin Kim, Young Hyeh Ko, Sanghyuk Lee   +11 more
doaj   +1 more source